NetworkNewsBreaks – Cannabis Global, Inc. (MCTC)
Post# of 112
Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced the successful application of production techniques developed for Tetrahydrocannabivarin (“THC-V”) to another rare cannabinoid, Cannabinol (“CBN”), which the Company believes may have enormous unexplored upside growth potential as a new cannabinoid-based products market. “Our research team already proved our capability to produce high-quality polymeric nanoparticles and fibers of THC-V, but we also consider it important to be able to leverage our production techniques relative to other rare cannabinoids,” Arman Tabatabaei, CEO of Cannabis Global, stated in the news release. “We are excited to report today the success of this effort, which comes in the form of the production of highly loaded nanofibers of CBN via our methods developed for THC-V. We believe this development allows Cannabis Global to more quickly expand our product portfolio as we continue to stake a claim in the rare cannabinoid sector, potentially unleashing underexploited growth potential in markets like CBN, with little or no real competition.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer